Quick Answer
PLUS THERAPEUTICS, INC. reported Total Revenue of $5.21 million for fiscal year 2025.
PLUS THERAPEUTICS, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $5.21M | -10.5% |
| 2024 | $5.82M | +18.5% |
| 2023 | $4.91M | +33.8% |
| 2018 | $3.67M | +36.5% |
| 2017 | $2.69M | -42.2% |
| 2016 | $4.66M | -3.8% |
| 2015 | $4.84M | -2.3% |
| 2014 | $4.95M | -30.5% |
| 2013 | $7.12M | -18.2% |
| 2012 | $8.71M | +9.1% |
| 2011 | $7.98M | -3.3% |
| 2010 | $8.25M | +41.4% |
| 2009 | $5.84M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.40M | -4.1% | +0.5% |
| June 30, 2025 | $1.39M | +8.7% | +31.3% |
| March 31, 2025 | $1.06M | -36.9% | -27.3% |
| September 30, 2024 | $1.46M | — | +13.8% |
| June 30, 2024 | $1.28M | — | -23.7% |
| March 31, 2024 | $1.68M | — | +138.5% |
| March 31, 2019 | $703.0K | -3.8% | -18.1% |
| September 30, 2018 | $858.0K | +83.7% | +30.0% |
- PLUS THERAPEUTICS, INC. showed a decrease of -10.5% in Total Revenue compared to the prior fiscal year.
- Over the 2009–2025 period, PLUS THERAPEUTICS, INC.’s total revenue has declined by 10.7% (from $5.84 million to $5.21 million).
- The most recent figure is from PLUS THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: